Ascendis Pharma ADR (ASND)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -409,125 | -521,070 | -614,453 | -453,810 | -478,572 |
| Depreciation Amortization | 19,168 | 20,467 | 18,921 | 18,209 | 10,793 |
| Accounts receivable | -128,345 | -35,470 | -12,149 | -7,878 | -2,280 |
| Accounts payable and accrued liabilities | 29,179 | 3,843 | 48,406 | 46,361 | 9,006 |
| Other Working Capital | -115,955 | -107,998 | -13,141 | -56,459 | -1,101 |
| Other Operating Activity | 273,741 | 134,403 | 50,148 | -40,544 | 151,966 |
| Operating Cash Flow | $-331,336 | $-505,825 | $-522,269 | $-494,121 | $-310,189 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 7,957 | 312,639 | 295,564 | 177,323 | 300,483 |
| PPE Investments | -516 | -2,588 | -5,220 | -28,671 | -18,846 |
| Purchase Of Investment | N/A | N/A | -225,304 | -279,478 | -614,274 |
| Investing Cash Flow | $7,441 | $310,051 | $65,041 | $-130,826 | $-332,637 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 145,172 | 147,470 | 530,257 | N/A | N/A |
| Debt Repayment | -12,298 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 368,376 | 11,133 | 5,429 | 448,893 | 729,698 |
| Common Stock Repurchased | N/A | N/A | -110,949 | -25,561 | N/A |
| Other Financing Activity | -20,875 | -13,258 | -6,697 | -7,606 | -41,291 |
| Financing Cash Flow | $480,376 | $145,344 | $418,040 | $415,726 | $688,407 |
| Exchange Rate Effect | 24,641 | -6,503 | 37,607 | 45,657 | -61,104 |
| Beginning Cash Position | 424,361 | 481,371 | 470,187 | 691,542 | 683,217 |
| End Cash Position | 605,482 | 424,439 | 468,607 | 527,979 | 667,694 |
| Net Cash Flow | $181,121 | $-56,932 | $-1,580 | $-163,564 | $-15,523 |
| Free Cash Flow | |||||
| Operating Cash Flow | -331,336 | -505,825 | -522,269 | -494,121 | -310,189 |
| Capital Expenditure | -1,544 | -2,643 | -15,266 | -28,671 | -24,619 |
| Free Cash Flow | -332,880 | -508,468 | -537,534 | -522,792 | -334,808 |